Archive: 27/10/2020
Immunotherapy drug approved for head and neck cancer
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Oct 27, 2020
Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.
Oct 27, 2020